The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTRG.L Regulatory News (TRG)

  • There is currently no data for TRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison issues review on TR European Growth Trust

23 Mar 2021 07:00

RNS Number : 0639T
TR European Growth Trust PLC
23 March 2021
 

 

London, UK, 23 March 2021

 

Edison issues review on TR European Growth Trust (TRG)

TR European Growth Trust (TRG) has enjoyed a stellar period of performance since the COVID-19-driven stock market sell-off in March 2020 (beating the benchmark by c 25pp over one year to 28 February 2021), helped by its managers sticking to their valuation-aware investment process, as well as a timely increase in the trust's gearing. Lead manager Ollie Beckett says the team is optimistic on the prospects for small-cap European stocks - many of which have stronger balance sheets than their large-cap counterparts - as the economy recovers. TRG has a broadly diversified portfolio of c 130 stocks, allowing the managers to look for high-growth micro-caps as well as structural growth stories and recovery plays. Although the trust is now at the top of its peer group for NAV total returns over one and 10 years, it trades at the widest discount to NAV, suggesting significant scope for a re-rating similar to that seen in 2016/17.

 

TRG has suffered in the past few years as its main area of focus - underappreciated European small-caps - has been largely ignored by investors. The portfolio offers a good mix of growth and value, with a focus on cash-generative companies helping it to achieve portfolio income in H121 that was above the pre-pandemic level of H119, and a c 5% increase in the recently announced interim dividend compared with H120. Recent performance has been strong as the managers have stuck to their tried-and-tested process, assisted by greater investor appreciation of stocks with social and environmental benefits. We note that in the last sustained period of value stock outperformance in 2016/17, TRG's shares traded at a premium to NAV, and there is thus significant scope for a re-rating from the current c 13% discount.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Sarah Godfrey +44 (0)20 3681 2519 investmenttrusts@edisongroup.com

Mel Jenner +44 (0)20 3077 5720 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn https://www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADZGZFZZGGMZM
Date   Source Headline
18th Jan 202211:30 amRNSNet Asset Value(s)
18th Jan 20227:00 amRNSCompany name and ticker change
17th Jan 20223:39 pmRNSNet Asset Value(s)
14th Jan 202212:38 pmRNSNet Asset Value(s)
13th Jan 202212:15 pmRNSNet Asset Value(s)
12th Jan 202212:05 pmRNSNet Asset Value(s)
11th Jan 202212:06 pmRNSNet Asset Value(s)
10th Jan 20223:34 pmRNSNet Asset Value(s)
7th Jan 202212:56 pmRNSNet Asset Value(s)
6th Jan 202211:40 amRNSNet Asset Value(s)
5th Jan 202211:55 amRNSNet Asset Value(s)
4th Jan 20222:44 pmRNSChange to director information
4th Jan 20222:26 pmRNSNet Asset Value(s)
31st Dec 202111:51 amRNSNet Asset Value(s)
30th Dec 202111:48 amRNSNet Asset Value(s)
29th Dec 202111:52 amRNSNet Asset Value(s)
24th Dec 202110:34 amRNSNet Asset Value(s)
23rd Dec 202112:29 pmRNSNet Asset Value(s)
22nd Dec 20214:18 pmRNSMonthly Factsheet as at 30 November 2021
22nd Dec 202111:43 amRNSNet Asset Value(s)
21st Dec 202111:56 amRNSNet Asset Value(s)
20th Dec 20212:59 pmRNSNet Asset Value(s)
17th Dec 20211:15 pmRNSNet Asset Value(s)
16th Dec 202112:43 pmRNSNet Asset Value(s)
15th Dec 202111:27 amRNSNet Asset Value(s)
14th Dec 202111:00 amRNSNet Asset Value(s)
13th Dec 20215:16 pmRNSNet Asset Value(s)
13th Dec 20211:20 pmRNSShare split and total voting rights
10th Dec 202112:06 pmRNSNet Asset Value(s)
9th Dec 202111:01 amRNSNet Asset Value(s)
8th Dec 202112:12 pmRNSNet Asset Value(s)
7th Dec 202112:24 pmRNSNet Asset Value(s)
6th Dec 20213:00 pmRNSNet Asset Value(s)
6th Dec 20217:00 amRNSEdison issues review on TR European Growth Trust
3rd Dec 202112:10 pmRNSNet Asset Value(s)
2nd Dec 20211:08 pmRNSNet Asset Value(s)
1st Dec 202112:14 pmRNSNet Asset Value(s)
30th Nov 202112:16 pmRNSNet Asset Value(s)
29th Nov 20213:29 pmRNSNet Asset Value(s)
29th Nov 20213:13 pmRNSResult of AGM
26th Nov 202112:50 pmRNSNet Asset Value(s)
25th Nov 20211:52 pmRNSNet Asset Value(s)
24th Nov 202112:43 pmRNSNet Asset Value(s)
23rd Nov 20211:04 pmRNSNet Asset Value(s)
22nd Nov 20213:18 pmRNSNet Asset Value(s)
19th Nov 202112:52 pmRNSNet Asset Value(s)
18th Nov 20213:10 pmRNSMonthly Factsheet as at 31 October 2021
18th Nov 20211:24 pmRNSNet Asset Value(s)
17th Nov 202112:00 pmRNSNet Asset Value(s)
16th Nov 202112:22 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.